Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Atomic AI generates the structure data it needs for its AI model with the aim of RNA drug discovery.
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Townshend, R. J. L. et al. Science 373, 1047–1051 (2021).
Boyd, N. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.12.13.571579 (2023).
National Academies of Sciences, Engineering, and Medicine. Charting a Future for Sequencing RNA and its Modifications: A New Era for Biology and Medicine (National Academies Press, 2024); https://doi.org/10.17226/27165
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marx, V. Editor’s pick: Atomic AI. Nat Biotechnol 42, 1341–1342 (2024). https://doi.org/10.1038/s41587-024-02375-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-024-02375-0
